Atlas Trials

Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris

Clinical trial NCT04023149 · UNKNOWN

Trial details

NCT number
NCT04023149
Sponsor
Second Xiangya Hospital of Central South University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Pemphigus Vulgaris
Start date
2020-04-02
Primary completion
2021-06-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.